Evome Medical Technologies Inc. (LNDZF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 4, 2025
LNDZF Revenue
Evome Medical Technologies had revenue of 10.01M CAD in the quarter ending September 30, 2024, a decrease of -49.05%. This brings the company's revenue in the last twelve months to 48.34M, down -16.32% year-over-year. In the year 2023, Evome Medical Technologies had annual revenue of 62.63M with 55.35% growth.
Revenue (ttm)
48.34M CAD
Revenue Growth
-16.32%
P/S Ratio
0.01
Revenue / Employee
235.82K CAD
Employees
205
Market Cap
301.24K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 62.63M | 22.31M | 55.35% |
| Dec 31, 2022 | 40.31M | 22.00M | 120.15% |
| Feb 28, 2022 | 18.31M | 3.19M | 21.08% |
| Dec 31, 2021 | 15.12M | 15.16M | - |
| Feb 28, 2021 | -33.55K | -385.68K | - |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Venus Concept | 58.88M |
| Sonendo | 31.70M |
| Telesis Bio | 17.03M |
| Escalon Medical | 11.94M |
| Electromedical Technologies | 922.01K |
| AI Maverick Intel | 92.26K |
Evome Medical Technologies News
- 11 months ago - Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies - GlobeNewsWire
- 11 months ago - Evome Medical Technologies Provides Market Update - GlobeNewsWire
- 11 months ago - Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six - GlobeNewsWire
- 1 year ago - CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring - GlobeNewsWire
- 1 year ago - Evome Medical Technologies Announces Significant Debt Reduction and Restructuring - GlobeNewsWire
- 1 year ago - Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer - GlobeNewsWire
- 1 year ago - Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt - GlobeNewsWire
- 1 year ago - Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders - GlobeNewsWire